1-4 of 4
Roy B. Jones, MD, Ph.D
Close
Sort by
Journal Articles

Sequential Treatment After Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia.

Sairah Ahmed, MD, Rima M Saliba, Ph.D, Marcos De Lima, MD, Gabriela Rondon, MD, Partow Kebriaei, MD, Tobi DeAnn Fisher, MPAS, Elias Jabbour, MD, Julianne Chen, Hagop Kantarjian, MD, Paolo Anderlini, MD, Amin M Alousi, MD, Chitra M Hosing, MD, Borje Andersson, MD, PhD, Roy B. Jones, MD, Ph.D., Muzaffar H. Qazilbash, MD, Elizabeth J. Shpall, MD, Sergio Giralt, MD, Richard E Champlin, MD
Journal: Blood
Blood (2012) 120 (21): 3129.
https://doi.org/10.1182/blood.V120.21.3129.3129
Published: 2012
Journal Articles

A Matched Controlled Analysis of Post-Transplant Cyclophosphamide (CY) Versus Tacrolimus and Mini-Dose Methotrexate in Matched Sibling and Unrelated Donor Transplant Recipients Receiving Reduced-Intensity Conditioning: Post-Transplant CY Is Associated with Higher Rates of Acute Gvhd

Amin M. Alousi, M.D., Rima M Saliba, PhD, Julianne Chen, Borje S Andersson, MD, PhD, Issa Khouri, MD, Muzaffar H. Qazilbash, MD, Uday R. Popat, M.D., Chitra M. Hosing, M.D., Stefan O. Ciurea, Elizabeth J Shpall, MD, Roy B. Jones, MD, Ph.D., Partow Kebriaei, M.D., Yago Nieto, M.D., Ph.D., Paolo Anderlini, MD, Marcos DeLima, MD, Gabriela Rondon, Richard E. Champlin
Journal: Blood
Blood (2012) 120 (21): 4200.
https://doi.org/10.1182/blood.V120.21.4200.4200
Published: 2012
Journal Articles

Outcomes of Adults with Acute Lymphoblastic Leukemia (ALL) Following Relapse After First Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Amir Hamdi, M.D., LM Poon, M.D., Rima M. Saliba, Ph.D., Gabriela Rondon, M.D., Celina Ledesma, Muzaffar Qazilbash, M.D., Chitra M. Hosing, M.D., Roy B. Jones, MD, Ph.D., Uday R. Popat, M.D., Nieto, M.D., Ph.D., Amin M. Alousi, M.D., Stefan O. Ciurea, Elizabeth J. Shpall, M.D., Richard E. Champlin, Partow Kebriaei, M.D.
Journal: Blood
Blood (2012) 120 (21): 4215.
https://doi.org/10.1182/blood.V120.21.4215.4215
Published: 2012
Journal Articles

Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan: A New Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Muzaffar H. Qazilbash, MD, Marilyn S. Davis, Aleman Ana, Linda Roden, Floralyn Libunao, Peter F. Thall, PhD, Xuemei Wang, Daniel Couriel, MD, Marcos De Lima, MD, Chitra Hosing, MD, Partow Kebriaei, MD, Donna Weber, MD, Michael Wang, MD, Roy B. Jones, MD, Ph.D, Steven G. Matthes, Richard E. Champlin, MD, Sergio A. Giralt, MD
Journal: Blood
Blood (2005) 106 (11): 1159.
https://doi.org/10.1182/blood.V106.11.1159.1159
Published: 2005